Literature DB >> 9060842

Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.

P J Marie1, C de Pollak, P Chanson, A Lomri.   

Abstract

We studied the osteoblastic abnormalities resulting from activating mutation of the Gs alpha gene in two patients with McCune-Albright syndrome and one patient with monostotic fibrous dysplasia. Histomorphometric analysis of dysplastic lesions showed a low number of differentiated osteoblasts along the bone surface and numerous immature alkaline phosphatase-positive mesenchymal cells actively depositing a woven bone matrix. Osteoblastic cells isolated from dysplastic bone lesions expressed a missense mutation in the Gs alpha gene in position 201 and showed increased intracellular basal cyclic adenosine 3',5'-monophosphate levels compared with normal cells isolated from a noninvolved area in the same patient. Cell proliferation evaluated by DNA synthesis was two-fold to threefold greater in osteoblastic cells expressing the mutation compared with normal cells from the same patient and was greater in cells isolated from more severe than less severe fibrotic lesions. In contrast, the synthesis of osteocalcin, a marker of mature osteoblasts, was lower in osteoblastic cells expressing the Gs alpha mutation compared with normal cells from the same patient and was lower in cells isolated from severe compared with less severe fibrotic lesions, indicating that the increased growth in mutated osteoblastic cells was associated with reduced cell differentiation. The results show that activating mutation of Gs alpha in osteoblastic cells leads to constitutive activation of adenylate cyclase, increased cell proliferation, and inappropriate cell differentiation, resulting in overproduction of a disorganized fibrotic bone matrix in polyostotic and monostotic fibrous dysplasia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060842      PMCID: PMC1857873     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas.

Authors:  L Vallar; A Spada; G Giannattasio
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

2.  GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Authors:  C A Landis; S B Masters; A Spada; A M Pace; H R Bourne; L Vallar
Journal:  Nature       Date:  1989-08-31       Impact factor: 49.962

3.  Mutations in the GTP-binding site of GS alpha alter stimulation of adenylyl cyclase.

Authors:  S B Masters; R T Miller; M H Chi; F H Chang; B Beiderman; N G Lopez; H R Bourne
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

4.  Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces.

Authors:  P J Marie; A Lomri; A Sabbagh; M Basle
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

5.  Two G protein oncogenes in human endocrine tumors.

Authors:  J Lyons; C A Landis; G Harsh; L Vallar; K Grünewald; H Feichtinger; Q Y Duh; O H Clark; E Kawasaki; H R Bourne
Journal:  Science       Date:  1990-08-10       Impact factor: 47.728

6.  Fibrous dysplasia.

Authors:  S L Grabias; C J Campbell
Journal:  Orthop Clin North Am       Date:  1977-10       Impact factor: 2.472

7.  Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein.

Authors:  C A Landis; G Harsh; J Lyons; R L Davis; F McCormick; H R Bourne
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

8.  Increased mitogenic responsiveness of Swiss 3T3 cells expressing constitutively active Gs alpha.

Authors:  I Zachary; S B Masters; H R Bourne
Journal:  Biochem Biophys Res Commun       Date:  1990-05-16       Impact factor: 3.575

9.  Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation.

Authors:  P J Marie; M C de Vernejoul; D Connes; M Hott
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

10.  Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia.

Authors:  G A Candeliere; F H Glorieux; J Prud'homme; R St-Arnaud
Journal:  N Engl J Med       Date:  1995-06-08       Impact factor: 91.245

View more
  41 in total

1.  A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues.

Authors:  A Sakamoto; Y Oda; Y Iwamoto; M Tsuneyoshi
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

2.  CREB modulates calcium signaling in cAMP-induced bone marrow stromal cells (BMSCs).

Authors:  Linxia Zhang; Li Liu; Ryan Thompson; Christina Chan
Journal:  Cell Calcium       Date:  2014-08-06       Impact factor: 6.817

Review 3.  Fibrous dysplasia of bone: the bone lesion unmasked.

Authors:  F R Singer
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

4.  Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone.

Authors:  L M Calvi; N A Sims; J L Hunzelman; M C Knight; A Giovannetti; J M Saxton; H M Kronenberg; R Baron; E Schipani
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 5.  GNAS Spectrum of Disorders.

Authors:  Serap Turan; Murat Bastepe
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

Review 6.  Fibro-osseous lesions of the craniofacial skeleton: an update.

Authors:  Samir K El-Mofty
Journal:  Head Neck Pathol       Date:  2014-11-20

7.  Intramedullary rod fixation of fibrous dysplasia without use of bisphosphonates.

Authors:  Greg Gaski; Dane Hansen; Leisel M Willis; Gary D Bos; John R Kean
Journal:  J Child Orthop       Date:  2013-09-03       Impact factor: 1.548

Review 8.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

9.  Long-term efficacy of oral alendronate therapy in an elderly patient with polyostotic fibrous dysplasia: A case report.

Authors:  Gui-Dong Li; Akira Ogose; Tetsuo Hotta; Hiroyuki Kawashima; Takashi Ariizumi; Yongjun Xu; Naoto Endo
Journal:  Oncol Lett       Date:  2011-08-02       Impact factor: 2.967

10.  The identification of monoclonality in fibrous dysplasia by methylation-specific polymerase chain reaction for the human androgen receptor gene.

Authors:  Masae Mikami; Hirotaka Koizumi; Masamitsu Ishii; Hisaya Nakajima
Journal:  Virchows Arch       Date:  2003-10-24       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.